|Articles|December 8, 2022
The Evolving Relationship Between Sponsors and Contract Research Organizations
Author(s)ICON
If the last few years have taught us anything, it’s that so much more can be achieved when all players in the life sciences and pharmaceutical industries work together in a truly collaborative way. The opportunity for the clinical development industry is to take what we have learned about how we can work together and use this to continue to drive progress. To strategically support clients, at ICON, this means partnering with sponsors in a way that goes beyond a traditional CRO. It means being a trusted partner.
Trending on Applied Clinical Trials Online
1
Real-World Evidence in Transition: CRO Adaptation to the European Health Data Space Framework
2
ACT Brief: Sponsor Oversight Capability Gaps, Community-Embedded Trial Partnerships, and Trialblazer Timeline Realism
3
ACT Brief: Product Development Assumptions, Portfolio-Level Recruitment Infrastructure, and Risk-Based Quality Integration
4
Two New Partnerships Aim to Expand Patient Access to Clinical Trials Through Community-Based Research
5